Merck Attacks Watson, Actavis Over Birth Control Patent
Merck & Cie and a licensee accused Watson Laboratories Inc. and Actavis Inc. of infringing Merck's patent for birth control pill Beyaz when they applied for federal approval to manufacture a...To view the full article, register now.
Already a subscriber? Click here to view full article